Best Weight Loss Injections for Women in 2026 — Ranked & Reviewed
Semaglutide and tirzepatide are not gender-specific drugs, so the medication itself is identical whoever takes it. The program wrapped around it is what differs. In trial data, women lose weight on GLP-1s at rates equal to or a little above men's, and the questions that genuinely change which provider suits you are PCOS, perimenopause, how tirzepatide interacts with birth control, and pregnancy planning. Ranked below are injectable GLP-1 providers with real depth on exactly that: menopause-certified clinicians, programs that account for PCOS, and platforms built around women's care.
Lowest verified price: $79/mo12 providers compared
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
12 weight loss injections for women compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.
- ★ Editor's Pick
tirzepatide at $169/month, 37% under the register median
From /mo$99Coverage50 statesMedicationsSemaglutideTirzepatide - Best Budget
knowing which pharmacy fills the vial — it names RedRock Pharmacy
From /mo$79Coverage50 statesMedicationsSemaglutideTirzepatide semaglutide at $100/month, 47% under the register median
From /mo$100Coverage45 statesMedicationsSemaglutidestarting below a standard dose, with microdose tiers
From /mo$79CoverageCheck intakeMedicationsSemaglutideTirzepatideknowing which pharmacy fills the vial — it names Triad Rx
From /mo$99Coverage48 statesMedicationsSemaglutideTirzepatidecompounded semaglutide at $250/month
From /mo$250CoverageCheck intakeMedicationsSemaglutideTirzepatide- Nationwide Coverage
coverage in all 50 states, which most of the register will not confirm
From /mo$199Coverage50 statesMedicationsSemaglutideTirzepatide - Best Care Team
coaching bundled into the price rather than sold separately
From /mo$139Coverage15 statesMedicationsSemaglutideTirzepatide
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick tirzepatide at $169/month, 37% under the register median | $99 | SemaglutideTirzepatide | 50 states | Visit → | |
Best Budget knowing which pharmacy fills the vial — it names RedRock Pharmacy | $79 | SemaglutideTirzepatide | 50 states | Visit → | |
 semaglutide at $100/month, 47% under the register median | $100 | Semaglutide | 45 states | Visit → | |
 starting below a standard dose, with microdose tiers | $79 | SemaglutideTirzepatide | Check intake | Visit → | |
 knowing which pharmacy fills the vial — it names Triad Rx | $99 | SemaglutideTirzepatide | 48 states | Visit → | |
 compounded semaglutide at $250/month | $250 | SemaglutideTirzepatide | Check intake | Visit → | |
Nationwide Coverage coverage in all 50 states, which most of the register will not confirm | $199 | SemaglutideTirzepatide | 50 states | Visit → | |
Best Care Team coaching bundled into the price rather than sold separately | $139 | SemaglutideTirzepatide | 15 states | Visit → |
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
Detailed Reviews
Found
Verified partnerBest for: tirzepatide at $169/month, 37% under the register median
Found is a personalized weight care platform. It runs on a self-pay membership, and medication costs sit on top of that.
Score Breakdown
Pros
- ✓Tirzepatide at $169 a month, 37% below the $267 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly figure covers medication, consult, coaching
- ✓Coverage is published for all 50 states
- ✓No FDA warning letter matched this operator when we searched our enforcement register
Cons
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its orforglipron and semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Embody
Best for: knowing which pharmacy fills the vial — it names RedRock Pharmacy
Embody sells compounded semaglutide and tirzepatide by injection, plus a compounded oral tirzepatide gum that is unique in the category. Flat-rate pricing is aggressive, coverage runs to all 50 states, and clinician messaging is available 24/7 under a board-certified internal medicine CMO.
Score Breakdown
Pros
- ✓Semaglutide at $79 a month, 58% below the $189 median for the same drug and form across this register
- ✓Tirzepatide at $129 a month, 52% below the $267 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly figure covers medication, consult, shipping
- ✓Coverage is published for all 50 states
- ✓Names 4 dispensing pharmacies, which most sellers in this register do not do
- ✓No FDA warning letter matched this operator when we searched our enforcement register
- ✓Both oral and injectable options are on record, so the format is a choice rather than a condition
Cons
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Queen RX
Best for: semaglutide at $100/month, 47% under the register median
Queen RX charges $299 per quarter, roughly $100/mo, for compounded GLP-1 treatment covering semaglutide, tirzepatide and liraglutide. It sells in 45 states; KS, LA, MS, NM and WV are excluded.
Score Breakdown
Pros
- ✓Semaglutide at $100 a month, 47% below the $189 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly figure covers medication and consult
- ✓Coverage is published for 45 states
- ✓No FDA warning letter matched this operator when we searched our enforcement register
Cons
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Good Girl Rx
Best for: starting below a standard dose, with microdose tiers
Savannah Chrisley founded Good Girl Rx, registered as Good Girl LLC. Compounded semaglutide and tirzepatide come three ways: injectable, microdose, and oral dissolving tablet (ODT). Availability on the brand names, Mounjaro, Zepbound, Wegovy, and Ozempic, is limited, though all four are listed. Licensed 503A/503B pharmacies dispense, and the company holds LegitScript certification.
Score Breakdown
Pros
- ✓Semaglutide at $79 a month, 58% below the $189 median for the same drug and form across this register
- ✓Tirzepatide at $139 a month, 48% below the $267 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly figure covers medication, consult, shipping
- ✓A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
- ✓Both oral and injectable options are on record, so the format is a choice rather than a condition
Cons
- ✗No state list is on record here, so whether it serves your state cannot be confirmed from this page
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗1 FDA warning letter matched to this operator in our enforcement register — read what the letter alleges, since a letter discloses a problem rather than disqualifying a seller
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
MEDVi
Best for: knowing which pharmacy fills the vial — it names Triad Rx
Two clinical groups do the treating at MEDVi: CareGLP Affiliated P.C.s, plus clinicians from OpenLoop Health. Its weight-loss menu holds compounded GLP-1s, injections and tablets alike, the molecule being semaglutide, next to Zepbound and Wegovy under their brand names. Licensed US pharmacies fill all of it.
Score Breakdown
Pros
- ✓Semaglutide at $249 a month, within the normal band around this register's $189 median for the same drug and form
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly figure covers medication, consult, shipping, coaching
- ✓Coverage is published for 48 states
- ✓Names 3 dispensing pharmacies, which most sellers in this register do not do
Cons
- ✗1 FDA warning letter matched to this operator in our enforcement register — read what the letter alleges, since a letter discloses a problem rather than disqualifying a seller
- ✗Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
What a woman should check on a GLP-1 seller
Sex does not change the medication. It does change what competent care around the medication looks like. Depth on PCOS, on menopause, and on pregnancy planning is where the sellers on this page separate from one another.
What to check
- Hormonal health, covered or not. Weight and GLP-1 response both shift with PCOS and with perimenopause. Some sellers staff menopause-certified clinicians, or run a program written with PCOS in mind. A generic telehealth intake collects none of that information and so cannot act on it.
- Birth control and pregnancy in the intake. Oral contraception can be made less effective by tirzepatide, and a GLP-1 has to be stopped ahead of a pregnancy. Both facts belong in the intake form. Where they appear in a footnote instead, or nowhere, no screening happened.
- Anything addressing lean mass. Lean tissue leaves alongside fat when loss is fast. Protein targets and resistance training are how that is limited. Some sellers build both into the program and others ship the drug by itself.
Red flags
- Pharmacy unnamed and no LegitScript listing. Two disclosures are checkable on any compounded-GLP-1 seller: the 503A or 503B pharmacy filling the vial, and a LegitScript certification. When a site publishes neither, nothing about the contents of that vial can be confirmed from outside.
- Instant approval with no clinician you can reach. A prescriber is supposed to read the intake and stay available once dose questions start. Approval issued automatically, with nobody reachable afterward, means the medical layer was removed rather than streamlined.
- The advertised number is a first month. Headline figures here are usually qualified somewhere. Common forms are an opening rate that steps up with each dose increase, and a membership fee billed separately from the drug itself. Either one can double what leaves your account in month two.
- B12, MIC, or HCG sold for weight loss. Trial evidence for weight loss sits with the GLP-1 injections and nowhere else on this aisle. A clinic that lists lipotropic, B12, or HCG shots under weight loss is selling past the record, whatever its own site says.
Every seller listed above is scored on these criteria under our six-dimension methodology, with prices re-checked against the seller’s own live site.
How we rank, and what counts as “legit”
Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.
Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].
How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].
Frequently Asked Questions
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.